Notable Labs, Ltd.
NTBL · NASDAQ
6/30/2024 | 3/31/2024 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -3,100% | 100% | – | – |
| R&D Expenses | $2 | $2 | -$2 | $0 |
| G&A Expenses | $3 | $2 | $0 | $4 |
| SG&A Expenses | $3 | $2 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $4 | $0 | $3 |
| Operating Income | -$5 | -$4 | -$0 | -$3 |
| % Margin | -269,000% | -383,800% | – | – |
| Other Income/Exp. Net | $0 | $0 | -$1 | $1 |
| Pre-Tax Income | -$5 | -$4 | -$1 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$4 | -$1 | -$3 |
| % Margin | -260,950% | -376,600% | – | – |
| EPS | -0.55 | -0.42 | -0.39 | -1.19 |
| % Growth | -31% | -7.7% | 67.2% | – |
| EPS Diluted | -0.55 | -0.42 | -0.39 | -1.19 |
| Weighted Avg Shares Out | 9 | 9 | 2 | 2 |
| Weighted Avg Shares Out Dil | 9 | 9 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$4 | -$0 | -$5 |
| % Margin | -265,800% | -377,500% | – | – |